These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening. Turk S; Kovac A; Boniface A; Bostock JM; Chopra I; Blanot D; Gobec S Bioorg Med Chem; 2009 Mar; 17(5):1884-9. PubMed ID: 19223185 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold. Hrast M; Anderluh M; Knez D; Randall CP; Barreteau H; O'Neill AJ; Blanot D; Gobec S Eur J Med Chem; 2014 Feb; 73():83-96. PubMed ID: 24384549 [TBL] [Abstract][Full Text] [Related]
4. Biochemical characterization of MurF from Streptococcus pneumoniae and the identification of a new MurF inhibitor through ligand-based virtual screening. Turk S; Hrast M; Sosic I; Barreteau H; Mengin-Lecreulx D; Blanot D; Gobec S Acta Chim Slov; 2013; 60(2):294-9. PubMed ID: 23878932 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF. Sova M; Kovac A; Turk S; Hrast M; Blanot D; Gobec S Bioorg Chem; 2009 Dec; 37(6):217-22. PubMed ID: 19804894 [TBL] [Abstract][Full Text] [Related]
6. Peptide inhibitors of MurD and MurE, essential enzymes of bacterial cell wall biosynthesis. Bratkovic T; Lunder M; Urleb U; Strukelj B J Basic Microbiol; 2008 Jun; 48(3):202-6. PubMed ID: 18506905 [TBL] [Abstract][Full Text] [Related]
7. Design of inhibitors of the MurF enzyme of Streptococcus pneumoniae using docking, 3D-QSAR, and de Novo design. Khedkar SA; Malde AK; Coutinho EC J Chem Inf Model; 2007; 47(5):1839-46. PubMed ID: 17663541 [TBL] [Abstract][Full Text] [Related]
8. Identification of selective enzyme inhibitors by fragment library screening. Gao G; Liu X; Pavlovsky A; Viola RE J Biomol Screen; 2010 Oct; 15(9):1042-50. PubMed ID: 20855558 [TBL] [Abstract][Full Text] [Related]
9. Structure-based optimization of MurF inhibitors. Stamper GF; Longenecker KL; Fry EH; Jakob CG; Florjancic AS; Gu YG; Anderson DD; Cooper CS; Zhang T; Clark RF; Cia Y; Black-Schaefer CL; Owen McCall J; Lerner CG; Hajduk PJ; Beutel BA; Stoll VS Chem Biol Drug Des; 2006 Jan; 67(1):58-65. PubMed ID: 16492149 [TBL] [Abstract][Full Text] [Related]
10. Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization. Miller JR; Herberg JT; Tomilo M; McCroskey MC; Feilmeier BJ Anal Biochem; 2007 Jun; 365(1):132-43. PubMed ID: 17395144 [TBL] [Abstract][Full Text] [Related]
11. Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening. Miguet L; Zervosen A; Gerards T; Pasha FA; Luxen A; Distèche-Nguyen M; Thomas A J Med Chem; 2009 Oct; 52(19):5926-36. PubMed ID: 19746934 [TBL] [Abstract][Full Text] [Related]
12. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay. Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290 [TBL] [Abstract][Full Text] [Related]
13. Development of screening assays and discovery of initial inhibitors of pneumococcal peptidoglycan deacetylase PgdA. Bui NK; Turk S; Buckenmaier S; Stevenson-Jones F; Zeuch B; Gobec S; Vollmer W Biochem Pharmacol; 2011 Jul; 82(1):43-52. PubMed ID: 21501597 [TBL] [Abstract][Full Text] [Related]
14. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures. Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178 [TBL] [Abstract][Full Text] [Related]
15. Structure of MurF from Streptococcus pneumoniae co-crystallized with a small molecule inhibitor exhibits interdomain closure. Longenecker KL; Stamper GF; Hajduk PJ; Fry EH; Jakob CG; Harlan JE; Edalji R; Bartley DM; Walter KA; Solomon LR; Holzman TF; Gu YG; Lerner CG; Beutel BA; Stoll VS Protein Sci; 2005 Dec; 14(12):3039-47. PubMed ID: 16322581 [TBL] [Abstract][Full Text] [Related]
16. Affinity capillary electrophoresis for the screening of novel antimicrobial targets. Lewis LM; Engle LJ; Pierceall WE; Hughes DE; Shaw KJ J Biomol Screen; 2004 Jun; 9(4):303-8. PubMed ID: 15191647 [TBL] [Abstract][Full Text] [Related]
17. High-throughput screening for enzyme inhibitors using frontal affinity chromatography with liquid chromatography and mass spectrometry. Ng ES; Yang F; Kameyama A; Palcic MM; Hindsgaul O; Schriemer DC Anal Chem; 2005 Oct; 77(19):6125-33. PubMed ID: 16194069 [TBL] [Abstract][Full Text] [Related]
18. High-throughput screening of model bacteria. Zlitni S; Blanchard JE; Brown ED Methods Mol Biol; 2009; 486():13-27. PubMed ID: 19347613 [TBL] [Abstract][Full Text] [Related]
19. Affinity selection-mass spectrometry screening techniques for small molecule drug discovery. Annis DA; Nickbarg E; Yang X; Ziebell MR; Whitehurst CE Curr Opin Chem Biol; 2007 Oct; 11(5):518-26. PubMed ID: 17931956 [TBL] [Abstract][Full Text] [Related]
20. A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site. Foloppe N; Chen IJ; Davis B; Hold A; Morley D; Howes R Bioorg Med Chem; 2004 Mar; 12(5):935-47. PubMed ID: 14980606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]